NZ515581A - Fibrin sealants providing less inflammatory response and methods using same - Google Patents

Fibrin sealants providing less inflammatory response and methods using same

Info

Publication number
NZ515581A
NZ515581A NZ515581A NZ51558100A NZ515581A NZ 515581 A NZ515581 A NZ 515581A NZ 515581 A NZ515581 A NZ 515581A NZ 51558100 A NZ51558100 A NZ 51558100A NZ 515581 A NZ515581 A NZ 515581A
Authority
NZ
New Zealand
Prior art keywords
inflammatory response
methods
same
providing less
fibrin sealants
Prior art date
Application number
NZ515581A
Other languages
English (en)
Inventor
John E Fairbrother
Nigel Scott
Michael Walker
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NZ515581A publication Critical patent/NZ515581A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
NZ515581A 1999-06-01 2000-06-01 Fibrin sealants providing less inflammatory response and methods using same NZ515581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13690399P 1999-06-01 1999-06-01
PCT/US2000/015139 WO2000072856A1 (en) 1999-06-01 2000-06-01 Fibrin sealants providing less inflammatory response and methods using same

Publications (1)

Publication Number Publication Date
NZ515581A true NZ515581A (en) 2004-01-30

Family

ID=22474935

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515581A NZ515581A (en) 1999-06-01 2000-06-01 Fibrin sealants providing less inflammatory response and methods using same

Country Status (7)

Country Link
EP (1) EP1223955A1 (ja)
JP (1) JP2003500171A (ja)
AU (1) AU771328B2 (ja)
CA (1) CA2373706A1 (ja)
NO (1) NO20015760L (ja)
NZ (1) NZ515581A (ja)
WO (1) WO2000072856A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
US5230996A (en) * 1990-06-04 1993-07-27 Therapy 2000 Use of ascorbate and tranexamic acid solution for organ and blood vessel treatment prior to transplantation
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
WO1993008818A1 (en) * 1991-11-07 1993-05-13 The University Of Southern California Compositions and methods for preventing adhesion formation
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法

Also Published As

Publication number Publication date
JP2003500171A (ja) 2003-01-07
NO20015760L (no) 2002-01-30
WO2000072856A1 (en) 2000-12-07
EP1223955A1 (en) 2002-07-24
NO20015760D0 (no) 2001-11-26
AU771328B2 (en) 2004-03-18
AU5313400A (en) 2000-12-18
CA2373706A1 (en) 2000-12-07
WO2000072856A9 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
DE69822805D1 (de) Verbesserte arzneiverabreichung an schleimhautoberflächen
NO20016055L (no) Splitteanordning for murblokker med fremspring i n¶rheten av splitteblader
IS6828A (is) Nýjar afleiður möndlusýru og notkun þeirra sem þrombínhemla
AU5455200A (en) The use of encapsulated acid in acid fracturing treatments
AU1449401A (en) Method using prior activities to improve the completion of transaction
AU2001284816A1 (en) Multifunctional battery and method of making the same
NO308622B1 (no) Korrosjonsinhibitorformulering, inhibert surgjøringsoppløsning, og fremgangsmÕte for syrebehandling av en underjordisk formasjon
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
DK0782441T3 (da) Farmaceutisk kontrol af inflammation
ID27505A (id) Tomat tanpa-biji dan metode untuk menghasilkan tomat tanpa-biji dan tanaman tomat hibrida yang mampu menghasilkan tomat tanpa-biji tersebut
CA2403352A1 (en) Use of comt inhibitors as analgesics
NZ515581A (en) Fibrin sealants providing less inflammatory response and methods using same
WO2002011667A3 (en) Pharmaceutical compositions and methods useful for modulating angiogenesis
EP0363903A3 (en) Adhesive containing pit and fissure sealants
AU5327800A (en) Methods for treating skin with 3-hydroxy benzoic acid and related compositions
IL138709A0 (en) METHODS FOR PROMOTING THE HEALING OF CUTANEOUS WOUNDS AND ULCERS USING COMPOSITIONS OF α-D-GLUCANS
DE69918113D1 (de) Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf
PL349070A1 (en) Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
ATE269853T1 (de) Benzoxa- und benzthiazolylsulfamate sowie ihre verwendung als steroid-sulfataseinhibitoren
FI943441A0 (fi) Tris-karbamiinihapon estereitä: kolesterolin absorption ehkäisyaineita
AU7264494A (en) Detachable versatile anchoring and connecting construction for frameworks with prefabricated substructures
HU0204326D0 (en) Process for construction of building with prefabricated wall-elements as well as prefabricated foundation and other wall-elements
CA2438500A1 (en) Composition for electroporation
AU2544999A (en) Process for the execution of the foundation works of buildings erected with prefabricated structures
GB2359548B (en) Composition and method for the treatment of concrete and masonry

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)